MedTrace Logo

Agent-Enhanced Document Explanation

NCT02668705 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2016-11-25

No results posted yet for this study

Summary

Both the main and sub-studies will investigate how consent forms and other health care documents are explained to patients. The findings will be used to create a computer program that can successfully explain consent and other health-related forms to individuals who have difficulty reading and understanding consent forms on their own as a supplement to the normal consent process done in research settings.

Conditions

  • Mental Competency

Interventions

OTHER

Embodied Conversational Agent

A computer generated character that can administer informed consent to a potential research subject.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Northeastern University

    collaborator OTHER

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Michael Paasche-Orlow, MD, MPH · Boston Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02668705 on ClinicalTrials.gov